Found: 5
Select item for more details and to access through your institution.
Anti-CD19 chimeric antigen receptor T-cell followed by interferon−a therapy induces durable complete remission in donor cell-derived acute lymphoblastic leukemia: A case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021786
- By:
- Publication type:
- Article
TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.879471
- By:
- Publication type:
- Article
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
- Published in:
- Oncology Reports, 2023, v. 49, n. 2, p. N.PAG
- By:
- Publication type:
- Article
Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
- Published in:
- Oncology Reports, 2022, v. 47, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Mechanisms underlying the increased chemosensitivity of bortezomib-resistant multiple myeloma by silencing nuclear transcription factor Snail1.
- Published in:
- Oncology Reports, 2019, v. 41, n. 1, p. 415, doi. 10.3892/or.2018.6797
- By:
- Publication type:
- Article